Markell, Lauren Mordasky <br/><br/>
Pharmacologic inhibition of ALK5 causes selective induction of terminal differentiation in mouse keratinocytes expressing oncogenic HRAS.  [electronic resource] 

 -  Molecular cancer research : MCR  Jun 2011 
 - 746-56 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1557-3125 
<br/><br/><label>Standard No.: </label>10.1158/1541-7786.MCR-11-0112  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Benzamides--pharmacology<br/>Cell Differentiation--drug effects<br/>Cell Proliferation<br/>Cells, Cultured<br/>Dioxoles--pharmacology<br/>Genes, ras--genetics<br/>Humans<br/>Keratinocytes--drug effects<br/>Mice<br/>Protein Serine-Threonine Kinases--antagonists & inhibitors<br/>Receptor, Transforming Growth Factor-beta Type I<br/>Receptors, Transforming Growth Factor beta--antagonists & inhibitors<br/>Signal Transduction--genetics<br/>Transforming Growth Factor beta--metabolism<br/>Transglutaminases--metabolism